Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease

Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerative disease

US Patent 10995141 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Agent, uses and methods for treatment2025
Antibody molecules and uses thereof2025
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023